Antitrust Lyme Disease Probe Sparks Debate

Law360, New York (May 2, 2008, 12:00 AM EDT) -- Connecticut’s attorney general has settled his unprecedented antitrust investigation into an influential medical association’s Lyme disease treatment guidelines, but antitrust experts say the agreement may still have an interesting side effect: putting medical professionals on notice.

While professional organizations often come under scrutiny from regulators, antitrust actions involving disease treatment guidelines are rare.

Connecticut Attorney General Richard Blumenthal’s antitrust probe of the Infectious Disease Society of America’s process for setting Lyme Disease diagnosis and treatment guidelines has certainly raised questions for doctors, scientists and antitrust specialists....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.